Issue Date | Title | Involved Person(s) |
2015 | Gene expression signatures predictive of bevacizumab/erlotinib therapeutic benefit in advanced nonsquamous non-small cell lung cancer patients (SAKK 19/05 trial) | Franzini, Anca; Baty, Florent; Macovei, Ina I.; Dürr, Oliver; Droege, Cornelia, et al |
2014 | Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC) | Dürr, Oliver; Franzini, Anca; Brutsche, Martin; Baty, Florent |
17-Jul-2011 | Using community structure for complex network layout | Dürr, Oliver; Brandenburg, Arnd; Fink, Kerstin |
2007 | Robust hit identification by quality assurance and multivariate data analysis of a high-content, cell-based assay | Dürr, Oliver; Duval, François; Nichols, Anthony; Lang, Paul; Brodte, Annette, et al |
12-Sep-2006 | Multivariate analysis of siRNA / high content screening data | Dürr, Oliver |
2005 | Quantifying bioactivity on a large scale : quality assurance and analysis of multiparametric ultra-HTS data | Heyse, Stephan; Brodte, Annette; Bruttger, Oliver; Dürr, Oliver; Freeman, Tobe, et al |